DrZaN Pharma Research Consulting, Wolfratshausen, Germany.
Scand J Immunol. 2012 May;75(5):463-70. doi: 10.1111/j.1365-3083.2012.02680.x.
Alloreactivity, defined as a strong primary T cell response against allelic variants of major histocompatibility complex (MHC) molecules in the species, has been a long-standing puzzle in immunology with some of its details remaining unclear up to now. Here I shall provide a historical overview of how our understanding of alloreactivity has evolved and propose an interpretation that considers alloreactivity to be a mixture of four mechanistically distinct prototypes of T cell response, namely, self-restricted peptide specific, allorestricted peptide specific, alloreactive peptide dependent and alloreactive peptide independent. The relative contribution of each prototype to a given alloresponse is dependent on the extent of disparity (i.e. the number and nature of amino acid substitutions in the docking surface for T cell receptor) between the MHC molecule that the T cell recognizes as self and the stimulating MHC molecule.
同种异体反应性,定义为针对主要组织相容性复合体 (MHC) 分子等位变体的强烈初始 T 细胞反应,一直是免疫学中的一个长期存在的难题,其一些细节至今仍不清楚。在这里,我将提供一个历史概述,说明我们对同种异体反应性的理解是如何发展的,并提出一种解释,即认为同种异体反应性是四种机制上不同的 T 细胞反应原型的混合物,即自身限制的肽特异性、同种异体限制的肽特异性、同种异体反应性肽依赖性和同种异体反应性肽非依赖性。每个原型对特定同种反应的贡献取决于 T 细胞识别为自身的 MHC 分子与刺激 MHC 分子之间的差异程度(即 T 细胞受体结合表面的氨基酸取代数量和性质)。